Trials / Conditions / Advanced or Metastatic Biliary Tract Cancer
Advanced or Metastatic Biliary Tract Cancer
4 registered clinical trials studyying Advanced or Metastatic Biliary Tract Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract NCT04837508 | Shanghai Miracogen Inc. | Phase 2 |
| Unknown | A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract NCT04838964 | Shanghai Miracogen Inc. | Phase 2 |
| Withdrawn | Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer NCT03129074 | ASLAN Pharmaceuticals | Phase 2 |
| Completed | A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours NCT03082053 | ASLAN Pharmaceuticals | Phase 1 |